A C Bay-Jensen Selected Research

salmon calcitonin (Calcimar)

4/2015	Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.
4/2015	OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.
4/2011	Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials.
6/2010	Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A C Bay-Jensen Research Topics

Disease

17	Osteoarthritis 03/2020 - 06/2010
11	Inflammation (Inflammations) 01/2020 - 05/2012
5	Knee Osteoarthritis 01/2019 - 04/2015
4	Pain (Aches) 08/2018 - 01/2015
3	Bone Resorption 10/2013 - 06/2010
2	Overweight 12/2017 - 11/2017
2	Neoplasms (Cancer) 01/2016 - 05/2011
2	Ankylosing Spondylitis 10/2013 - 05/2012
2	Osteoporosis 10/2013 - 04/2011
1	Hypertrophy 01/2019
1	Arthralgia (Joint Pain) 08/2018
1	Weight Loss (Weight Reduction) 11/2017
1	Arthritis (Polyarthritis) 11/2017
1	Crohn Disease (Crohn's Disease) 01/2017
1	Hip Osteoarthritis (Coxarthrosis) 01/2015
1	Alkaptonuria 01/2015
1	Ovarian Neoplasms (Ovarian Cancer) 01/2015
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Metabolic Bone Diseases (Osteopenia) 10/2013
1	Neoplasm Metastasis (Metastasis) 05/2011
1	Disease Progression 05/2011

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2010
5	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 05/2012
4	salmon calcitonin (Calcimar)FDA LinkGeneric 04/2015 - 06/2010
3	Collagen Type II (Type II Collagen)IBA 11/2017 - 06/2010
3	CollagenIBA 01/2017 - 01/2014
2	fibroblast growth factor 18IBA 01/2020 - 11/2017
2	tanezumabIBA 01/2019 - 01/2017
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 01/2017
2	Collagen Type III (Type III Collagen)IBA 08/2018 - 01/2017
2	EnzymesIBA 01/2015 - 05/2014
2	catch-relaxing peptide (Mytilus)IBA 01/2015 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 05/2014 - 05/2011
2	C-Reactive ProteinIBA 01/2014 - 05/2012
2	Estrogens (Estrogen)FDA Link 10/2013 - 12/2012
1	Etanercept (Enbrel)FDA Link 03/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Collagen Type XIBA 01/2019
1	Nerve Growth Factor (NGF)IBA 01/2019
1	EpitopesIBA 01/2019
1	Proteoglycans (Proteoglycan)IBA 01/2019
1	aggrecanaseIBA 08/2018
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2017
1	Collagen Type V (Type V Collagen)IBA 01/2017
1	Complement C5 (Complement 5)IBA 01/2017
1	Complement C3 (C3 Complement)IBA 01/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017
1	BuffersIBA 01/2016
1	Fibronectins (Fibronectin)IBA 01/2016
1	nitisinone (Orfadin)FDA Link 01/2015
1	ImmunosorbentsIBA 01/2015
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	Metalloproteases (Metalloproteinases)IBA 05/2014
1	Cathepsin KIBA 10/2013
1	Biological ProductsIBA 10/2013
1	Diphosphonates (Bisphosphonates)IBA 10/2013
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2012
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2012
1	CathepsinsIBA 05/2012
1	Pharmaceutical PreparationsIBA 04/2011
1	TabletsIBA 04/2011
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2011
1	Peptides (Polypeptides)IBA 04/2011
1	Collagen Type I (Type I Collagen)IBA 06/2010

Therapy/Procedure

4	Therapeutics 03/2020 - 04/2011
1	Reducing Diet 11/2017
1	Replacement Arthroplasty 01/2017